Skip to content
10-Q

Quarterly Report

OSIRIS THERAPEUTICS, INC.

0001104659-18-032172

← back to feed
Filed
May 10, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 9, 2018 34.53M sh
Capex Q1 2018 · Mar 31, 2018 $100K
Capex Q1 2018 · Mar 31, 2017 $67K
Operating Cash Flow Q1 2018 · Mar 31, 2018 $337K
Operating Cash Flow Q1 2018 · Mar 31, 2017 −$4.24M
Cash And Equivalents Q1 2018 · Mar 31, 2018 $3.36M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $3.08M
Stockholders Equity Q1 2018 · Mar 31, 2018 $38.93M
Stockholders Equity Q1 2018 · Dec 31, 2017 $41.39M
Current Liabilities Q1 2018 · Mar 31, 2018 $37.15M
Current Liabilities Q1 2018 · Dec 31, 2017 $35.1M
Total Liabilities Q1 2018 · Mar 31, 2018 $39.64M
Total Liabilities Q1 2018 · Dec 31, 2017 $36.73M
Current Assets Q1 2018 · Mar 31, 2018 $73.27M
Current Assets Q1 2018 · Dec 31, 2017 $72.93M
Total Assets Q1 2018 · Mar 31, 2018 $78.58M
Total Assets Q1 2018 · Dec 31, 2017 $78.12M
Rd Expense Q1 2018 · Mar 31, 2018 $1.55M
Rd Expense Q1 2018 · Mar 31, 2017 $1.22M
Net Income Q1 2018 · Mar 31, 2018 −$2.32M
Net Income Q1 2018 · Mar 31, 2017 −$1.64M
Operating Income Q1 2018 · Mar 31, 2018 −$2.5M
Operating Income Q1 2018 · Mar 31, 2017 −$1.64M
Gross Profit Q1 2018 · Mar 31, 2018 $22.78M
Gross Profit Q1 2018 · Mar 31, 2017 $19.17M